Richard Furie

34PUBLICATIONS
104CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Molecular medicinePredictive and prognostic markersAstrodynamics and space situational awarenessCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 26, 2026
Anifrolumab Plus Standard of Care Reduces Long-Term Cardiovascular Damage in Adults With Systemic Lupus Erythematosus: Findings From a Real-World External Control Study.

|May 22, 2026
"More guidelines than rules": reconsidering key gaps in the 2025 American College of Rheumatology treatment recommendations for systemic lupus erythematosus: comment on the article by Sammaritano et al.

|Apr 28, 2026
Clinical, Histologic, and Serological Predictors of Renal Function Loss in Lupus Nephritis.

|Dec 30, 2025
Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: A Randomized, Phase 3 Study.

Susan Manzi, Ian N Bruce, Eric F Morand

|Oct 06, 2025
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment.

Andrea Fava, Catriona A Wagner, Carla J Guthridge

|Sep 08, 2025
Design of Two Randomized, Placebo-Controlled, Phase 3 Trials of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Systemic Lupus Erythematosus.

Cristina Arriens, Eric F Morand, Anca D Askanase

Pageof 6

Frequent Collaborators

10 joint publications

Eric Morand

6 joint publications

Yoshiya Tanaka

5 joint publications

Michelle Petri

5 joint publications

Ronald van Vollenhoven